Search

Your search keyword '"Smiley, Dia"' showing total 27 results
Start Over Author "Smiley, Dia"
27 results on '"Smiley, Dia"'

1. Prevalence and significance of extracardiac uptake on pyrophosphate imaging in the SCAN-MP study: the first 379 cases

Author

Chan, Nicholas, Einstein, Andrew J., Griffin, Jan M., Rosenblum, Hannah, Teruya, Sergio, Cuomo, Margaret, De Los Santos, Jeffeny, DeLuca, Albert, Johnson, Lynne L., Kinkhabwala, Mona P., Leb, Jay S., Mintz, Akiva, Fine, Denise, Helmke, Stephen, Muralidhar, Varsha, Pandey, Shivda, Sabogal, Natalia, Saith, Sunil E., Winburn, Morgan, Smiley, Dia, Miller, Edward J., Ruberg, Frederick L., and Maurer, Mathew S.

Published
2023
Full Text
View/download PDF

9. Quantitative Uptake of 124I-Evuzamitide on PET Correlates with Markers of Transthyretin Cardiac Amyloidosis, Quality of Life, and Functional Status

Author

SMILEY, DIA, primary, Einstein, Andrew, primary, Mateo, Kimberly, primary, Santana, Denisse, primary, Goldner, Kimberly, primary, Nalbandian, Ani, primary, Mintz, Akiva, primary, Teruya, Sergio, primary, Helmke, Stephen, primary, Rodriguez, Carlos, primary, Jimenez, Massiel, primary, Paulino, Mary, primary, Mirabal, Alfonsina, primary, Chan, Nicholas, primary, Wardhere, Abdirahman, primary, Bampatsias, Dimitrios, primary, Guadalupe, Samantha, primary, De, Jeffeny, primary, Cuomo, Margaret, primary, and Maurer, Mathew, primary

Published
2024
Full Text
View/download PDF

12. Validation Of The Transthyretin Amyloidosis Cardiomyopathy Score In A Black And Hispanic Screening Population: An Interim Analysis Of The First 342 Cases From The Scan-mp Study

Author

Chan, Nicholas, primary, Einstein, Andrew, additional, Teruya, Sergio, additional, Rodriguez, Carlos, additional, Helmke, Stephen, additional, Cuomo, Margaret, additional, DeLuca, Albert, additional, Johnson, Lynne, additional, Kinkhabwala, Mona, additional, Santana, Denisse, additional, Castillo, Michelle, additional, Smiley, Dia, additional, Sabogal, Natalia, additional, Lamour, Sendy, additional, Winburn, Morgan, additional, Fine, Denise, additional, De Freitas, Cinthia, additional, Kattan, Cesia Gallegos, additional, Miller, Edward, additional, Ruberg, Frederick, additional, and Maurer, Mathew, additional

Published
2024
Full Text
View/download PDF

17. Analysis of lumbar spine stenosis specimens for identification of amyloid

Author

Maurer, Mathew S., primary, Smiley, Dia, additional, Simsolo, Eli, additional, Remotti, Fabrizio, additional, Bustamante, Angela, additional, Teruya, Sergio, additional, Helmke, Stephen, additional, Einstein, Andrew J., additional, Lehman, Ronald, additional, Giles, Jon T., additional, Kelly, Jeffery W., additional, Tsai, Felix, additional, Blaner, William S., additional, Brun, Pierre‐Jacques, additional, Riesenburger, Ron I., additional, Kryzanski, James, additional, Varga, Cindy, additional, and Patel, Ayan R., additional

Published
2022
Full Text
View/download PDF

19. In the thick of it: hereditary cardiac amyloidosis identified by 124I-AT-01 PET imaging but not cardiac MRI or SPECT 99mTc pyrophosphate scintigraphy.

Author

Smiley, Dia, Einstein, Andrew J., Chan, Nicholas, Mintz, Akiva, Santana, Denisse D., Shetty, Mrinali, Sekulic, Miroslav, Goldner, Kim, Wall, Jonathan, Helmke, Stephen, and Maurer, Mathew S.

Abstract

This case demonstrates that PET imaging with SP 124 sp I-AT-01 may detect cardiac amyloidosis when other currently available imaging modalities do not. 3 Evuzamitide as SPECT/CT Imaging Agent for Diagnosis of Transthyretin Amyloidosis. [Extracted from the article]

Published
2023
Full Text
View/download PDF

20. Left Atrial Dyssynchrony During Sinus Rhythm: A Predictor For Incident Atrial Fibrillation/Flutter In Transthyretin Cardiac Amyloidosis

Author

Chan, Nicholas, Smiley, Dia, Helmke, Stephen, Cuomo, Margaret, Teruya, Sergio, De Los Santos, Jeffeny, Guadalupe, Samantha, Mirabal, Alfonsina, Jimenez, Massiel, Paulino, Mary, Rodriguez, Carlos, Santana, Denisse, Mateo, Kimberly, Biviano, Angelo, Dizon, Jose, Wan, Elaine, Yarmohammadi, Hirad, and Maurer, Mathew

Published
2024
Full Text
View/download PDF

27. Quantitative interpretation of FDG PET for cardiac sarcoidosis reclassifies visually interpreted exams and potentially impacts downstream interventions.

Author

Varghese M, Smiley D, Bellumkonda L, Rosenfeld LE, Zaret B, and Miller EJ

Abstract

Background: FDG PET is used in cardiac sarcoidosis (CS) diagnosis and management, including decisions about initiation and titration of immunosuppression. However, optimal methods to identify sarcoidosis-related inflammation on these scans is unknown. Traditional interpretive methods for FDG PET rely on qualitative visual analysis, but quantitative techniques including standardized uptake values (SUVs) may be more specific. This study evaluated the diagnostic reclassification of FDG PET studies using quantitative versus qualitative analysis and evaluated the potential impact of reclassification on downstream management and events. Methods: Cardiac-focused FDG PET examinations performed for the evaluation of CS were analyzed, comparing results from the clinically reported visual analysis to quantitative re-analysis using left ventricular maximal SUV values (SUVmax). Net diagnostic reclassification index (NDI) was calculated and compared to admissions, deaths, ICD placements, immunosuppression initiation/escalation. Of 154 exams, 22 were reclassified from positive to negative using quantitative re-analysis whereas only 2 clinically reported negative exams were quantitatively reclassified to positive, leading to a NDI of -13.0%. In the quantitatively negative/clinically reported positive group, 11 patients had immunosuppression adjusted after 22 exams and 4 ICDs were placed. Conclusions: Quantitative re-analysis of FDG PET for CS led to an overall negative diagnostic reclassification from positive to negative. Studies that were clinically reported as positive by visual analysis but reclassified as negative by quantitative analysis had numerous medical interventions but few clinical events. The low event rate suggests the use of quantitative interpretation of FDG PET for CS may help in providing providers with a more targeted therapeutic framework. (Sarcoidosis Vasc Diffuse Lung Dis 2018; 35: 342-353) ., (Copyright: © 2018 SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES.)

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results